在《自然》杂志最近的一篇发表中，BioFront的抗寨卡病毒包膜单克隆抗体（项目 #BF-1176-56）被哈佛大学、圣保罗大学和沃尔特·里德陆军研究所的研究人员用于其题为《来自巴西寨卡病毒的疫苗保护》的研究中。

点击下方参考文献查看完整出版物，若您对本研究中使用的抗寨卡病毒包膜单克隆抗体有兴趣，请访问我们的产品页面。

In a recent publication of Nature, BioFront's anti-Zika virus envelope monoclonal antibody (Item #BF-1176-56) was used by researchers from Harvard, the University of Sao Paulo, and the Walter Reed Army Institute in their work entitled 'Vaccine Protection Against Zika from Brazil.'

Click the reference below for a look at the full publication and visit our product page if you are interested in more information about the anti-Zika virus envelope monoclonal antibody used in this study.

Larocca et al. Vaccine protection against Zika virus from Brazil. Nature (2016). doi:10.1038/nature18952.